The expression of ALK-wt, ALK-F1174L, or ALK-R1275Q in NC progenitors or in sympathetic neuroblasts is not sufficient to drive NB tumor formation in absence of MYCN or other NB prototypical genetic alterations (20–23). The gene discussed is ALK; the disease is neoplasm.